World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
64
Citations
12594
World Ranking
2959
National Ranking
1392

Kazutoyo Miura publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Kazutoyo Miura sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 223 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Kazutoyo Miura D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Kazutoyo Miura sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 64 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Kazutoyo Miura is affiliated with the National Institute of Allergy and Infectious Diseases in the United States. Their research activity spans multiple fields, primarily Medicine and Immunology and Microbiology, with a significant focus on Public Health, Environmental and Occupational Health, Immunology, Molecular Biology, Virology, and Infectious Diseases.

The central themes of Miura's work include Malaria Research and Control, Mosquito-borne diseases and control, vaccines and immunoinformatics approaches, Complement system in diseases, HIV Research and Treatment, Computational Drug Discovery Methods, and Invertebrate Immune Response Mechanisms.

Miura has contributed to several recent scientific publications, including:

  • Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination, 2021, Med
  • Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein, 2021, mSphere
  • Plasmodium falciparum -specific IgM B cells dominate in children, expand with malaria, and produce functional IgM, 2021, The Journal of Experimental Medicine
  • Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors, 2021, Cell Reports Medicine
  • Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responses, 2022, Immunity

Frequent collaborators in their research include Carole A. Long, Ababacar Diouf, Simon J. Draper, Sarah E. Silk, and Angela M. Minassian.

Miura's work has been published extensively in several scientific venues. The most frequent publication platforms are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • npj Vaccines
  • Nature Communications
  • Vaccines

Best Publications

  • Erratum: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

    A D Douglas;A R Williams;J J Illingworth;G Kamuyu

  • Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51

    Yimin Wu;Ruth D. Ellis;Donna Shaffer;Erica Fontes

  • The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

    Alexander D. Douglas;Andrew R. Williams;Joseph J. Illingworth;Gathoni Kamuyu

  • Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria.

    Elissa M. Malkin;Anna P. Durbin;David J. Diemert;Jetsumon Sattabongkot

  • The Plasmodium falciparum-Specific Human Memory B Cell Compartment Expands Gradually with Repeated Malaria Infections

    Greta E Weiss;Boubacar Zan Traoré;Kassoum Kayentao;Aissata Ongoiba

  • Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines

    Kazutoyo Miura;Andrew C. Orcutt;Olga V. Muratova;Louis H. Miller

  • ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans

    Susanne H Sheehy;Christopher J A Duncan;Sean C Elias;Prateek Choudhary

  • A PfRH5-Based Vaccine Is Efficacious against Heterologous Strain Blood-Stage Plasmodium falciparum Infection in Aotus Monkeys

    Alexander D. Douglas;G. Christian Baldeviano;Carmen M. Lucas;Luis A. Lugo-Roman

  • A Randomized Controlled Phase 2 Trial of the Blood Stage AMA1-C1/Alhydrogel Malaria Vaccine in Children in Mali

    Issaka Sagara;Alassane Dicko;Ruth D. Ellis;Michael P. Fay

  • Immunity to Recombinant Plasmodium falciparum Merozoite Surface Protein 1 (MSP1): Protection in Aotus nancymai Monkeys Strongly Correlates with Anti-MSP1 Antibody Titer and In Vitro Parasite-Inhibitory Activity

    Sanjay Singh;Kazutoyo Miura;Hong Zhou;Olga Muratova

  • Phase Ia Clinical Evaluation of the Plasmodium Falciparum Blood-Stage Antigen MSP1 in ChAd63 and MVA Vaccine Vectors

    Susanne H Sheehy;Christopher J A Duncan;Sean C Elias;Katharine A Collins

  • Phase Ia Clinical Evaluation of the Safety and Immunogenicity of the Plasmodium falciparum Blood-Stage Antigen AMA1 in ChAd63 and MVA Vaccine Vectors

    Susanne H. Sheehy;Christopher J. A. Duncan;Sean C. Elias;Sumi Biswas

  • Qualification of standard membrane-feeding assay with Plasmodium falciparum malaria and potential improvements for future assays.

    Kazutoyo Miura;Bingbing Deng;Gregory Tullo;Ababacar Diouf

  • The heme biosynthesis pathway is essential for Plasmodium falciparum development in mosquito stage but not in blood stages.

    Hangjun Ke;Paul A. Sigala;Kazutoyo Miura;Joanne M. Morrisey

  • Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies.

    Daniel G.W. Alanine;Doris Quinkert;Rasika Kumarasingha;Shahid Mehmood

  • Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions

    Ruth O. Payne;Sarah E. Silk;Sean C. Elias;Kazutoyo Miura

  • Enhancing Blockade of Plasmodium falciparum Erythrocyte Invasion: Assessing Combinations of Antibodies against PfRH5 and Other Merozoite Antigens

    Andrew R. Williams;Alexander D. Douglas;Kazutoyo Miura;Joseph J. Illingworth

  • Naturally acquired antibodies specific for plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria

    Tuan M. Tran;Aissata Ongoiba;Jill Coursen;Cecile Crosnier

  • Supergenomic network compression and the discovery of EXP1 as a glutathione transferase inhibited by artesunate

    Andreas Martin Lisewski;Joel P. Quiros;Caroline L. Ng;Anbu Karani Adikesavan

  • Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination.

    Angela M. Minassian;Sarah E. Silk;Jordan R. Barrett;Carolyn M. Nielsen

  • Phase 1 trial of AMA1-C1/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malaria.

    Gregory E. D. Mullen;Ruth D. Ellis;Kazutoyo Miura;Elissa Malkin

Frequent Co-Authors

Carole A. Long
Carole A. Long National Institute of Allergy and Infectious Diseases
Louis H. Miller
Louis H. Miller National Institute of Allergy and Infectious Diseases
Simon J. Draper
Simon J. Draper University of Oxford
Rick M. Fairhurst
Rick M. Fairhurst AstraZeneca (United Kingdom)
David L. Narum
David L. Narum National Institutes of Health
Allan Saul
Allan Saul Burnet Institute
Adrian V. S. Hill
Adrian V. S. Hill University of Oxford
Ogobara K. Doumbo
Ogobara K. Doumbo University of Bamako
Takafumi Tsuboi
Takafumi Tsuboi Ehime University
Gavin J. Wright
Gavin J. Wright Wellcome Sanger Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can open up diverse career opportunities. Accelerated nursing programs are an excellent option for those looking to quickly transition into nursing. These programs offer a fast-track pathway and often provide flexible online options tailored to busy schedules. If you’re seeking a more accessible entry point, there are numerous lpn schools easy to get into, which can help you build foundational clinical skills before advancing further.

For those aiming to advance their practice and take on greater responsibilities, understanding what is the easiest np program can guide you toward nurse practitioner degrees that fit your lifestyle and career goals without overwhelming demands. Additionally, specializing in mental health is a growing field, and researching the best online pmhnp programs with best clinical placement rates can ensure you receive quality training and meaningful hands-on experience essential for success.

These pathways complement Immunology studies by blending scientific knowledge with clinical practice, preparing graduates for impactful roles in healthcare settings. The variety of online degree options accommodates different learning styles and timelines, making it easier to pursue meaningful careers in nursing and related health sciences.

Best Scientists Citing Kazutoyo Miura

Trending Scientists

Recently Published Articles